The expression of the MRPL3 is upregulated in breast tumor tissues, positively correlating with cancer progression, receiver operating characteristic(ROC) curve and Kaplan-Meier survival analyses, which indicates its potential as a diagnostic and prognostic biomarker for breast cancer (31). Here, MRPL3 is linked to breast carcinoma.